Quality Control for Medical Devices: A Review of Detection Technologies, Regulatory Standards and Matrix Interference Solutions
Sensors · 30.07.2026 · 26 (15) · 4821
DOI: 10.3390/s26154821 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Sensors, online erschienen am 30.07.2026. Verfasst von Xindan Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Guangzhou Medical Devices Testing Center, Guangzhou Quality Testing & Inspection Institute, Guangzhou 511447, China. Hauptthemen laut MEDLINE: Biosensing Techniques, Equipment and Supplies. Die Arbeit nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Project of the State Administration for Market Regulation, Science and Technology Project of Guangzhou Medical Devices Testing Center.
Abstract (Originalsprache)
Lipopolysaccharide (LPS), as the core active component of endotoxins from Gram-negative bacteria, serves as a mandatory quality control indicator in the biological safety evaluation of blood- and body fluid-contacting medical devices. Its rapid and accurate detection is of paramount importance for ensuring clinical patient safety and meeting global regulatory compliance requirements. Traditional endotoxin detection methods have inherent limitations, including poor anti-interference capability against medical device-specific matrices, limited automation capacity, and narrow regulatory applicability, which hinder their utility in meeting the practical demands of the modern medical device industry for high-throughput online quality control and on-site rapid screening. This review focuses on medical device-specific regulatory requirements, characteristics of extract matrices, and full-process quality control scenarios, and systematically summarizes the research progress in novel LPS-targeted biosensing detection technologies. By constructing a three-layer technical framework (biological recognition, interface engineering, and system integration), we provide a comparative assessment of four mainstream technologies—TLR4 biomimetic sensing, genetically engineered elements, EIS, and microfluidics—based on their matrix compatibility, automation potential, and regulatory compliance. It deeply analyzes the core role of microfluidic integration technology in driving the upgrading of detection systems towards automation, miniaturization and compliance, and objectively evaluates the applicability and limitations of various technologies in medical device scenarios. Unlike general reviews on LPS detection, this work specifically addresses endotoxin testing within the medical device quality control context. We systematically examine device-specific matrix interferences and regulatory landscapes, synthesizing cutting-edge research with critical analysis of industrialization bottlenecks. This review provides a theoretical foundation and technical roadmap for developing next-generation, pharmacopeial-compliant rapid automated endotoxin detection platforms—accelerating the advancement of medical device safety standards.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangzhou Medical Devices Testing Center, Guangzhou Quality Testing & Inspection Institute, Guangzhou 511447, China.
Förderung
- Science and Technology Project of the State Administration for Market Regulation
- Science and Technology Project of Guangzhou Medical Devices Testing Center
Zitieren
APA
Zhang, X., Xian, Y., & He, G. (2026). Quality Control for Medical Devices: A Review of Detection Technologies, Regulatory Standards and Matrix Interference Solutions. Sensors, 26(15), 4821. https://doi.org/10.3390/s26154821
Vancouver
Zhang X, Xian Y, He G. Quality Control for Medical Devices: A Review of Detection Technologies, Regulatory Standards and Matrix Interference Solutions. Sensors. 2026;26(15):4821. doi:10.3390/s26154821
BibTeX
@article{Zhang2026,
author = {Zhang, Xindan and Xian, Yanping and He, Guoshan},
title = {Quality Control for Medical Devices: A Review of Detection Technologies, Regulatory Standards and Matrix Interference Solutions},
journal = {Sensors},
year = {2026},
volume = {26},
number = {15},
pages = {4821},
doi = {10.3390/s26154821}
}
EUVIMED